Bank of America
ENTX icon

Bank of America’s Entera Bio ENTX Stock Holding History

Bank of America’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,000
Closed -$13.3K – 5717
2026
Q1 		$13.3K Sell
12,000
-3,000
-20% -$4.21K ﹤0.01% 5668
2025
Q4 		$29.1K Sell
15,000
-6,000
-29% -$14.1K ﹤0.01% 5970
2025
Q3 		$40.3K Sell
21,000
-2,430
-10% -$4.65K ﹤0.01% 6901
2025
Q2 		$44.5K Sell
23,430
-7,557
-24% -$14.9K ﹤0.01% 6851
2025
Q1 		$52.7K Buy
30,987
+22,557
+268% +$49.1K ﹤0.01% 6729
2024
Q4 		$17.9K Hold
8,430
– – ﹤0.01% 6870
2024
Q3 		$16K Buy
8,430
+5,430
+181% +$9.64K ﹤0.01% 6791
2024
Q2 		$5.52K Buy
+3,000
New +$6.57K ﹤0.01% 6990
2022
Q1 		– Sell
-13,866
Closed -$39K – 8385
2021
Q4 		$39K Sell
13,866
-2,307
-14% -$8.64K ﹤0.01% 7311
2021
Q3 		$76K Buy
+16,173
New +$82.9K ﹤0.01% 6858

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Bank of America's ENTX Position: Q2 2026 in Review

Bank of America sold out of Entera Bio (ENTX) in Q2 2026, closing a stake of 12,000 shares — an estimated $13.3K sold.

Bank of America first reported a position in ENTX in Q3 2021 and held it in 10 quarters. The position peaked at $76K in Q3 2021. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Bank of America reported no remaining Entera Bio position as of Q2 2026 after selling out during the quarter.
  • Bank of America sold 12,000 Entera Bio shares in Q2 2026, an estimated $13.3K.
  • Bank of America first reported a position in Entera Bio in Q3 2021 and held it in 10 quarters.
  • Bank of America's Entera Bio position peaked at $76K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.